BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37367045)

  • 1. DDIT4 Downregulation by siRNA Approach Increases the Activity of Proteins Regulating Fatty Acid Metabolism upon Aspirin Treatment in Human Breast Cancer Cells.
    Savukaitytė A; Bartnykaitė A; Bekampytė J; Ugenskienė R; Juozaitytė E
    Curr Issues Mol Biol; 2023 May; 45(6):4665-4674. PubMed ID: 37367045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. siRNA Knockdown of REDD1 Facilitates Aspirin-Mediated Dephosphorylation of mTORC1 Target 4E-BP1 in MDA-MB-468 Human Breast Cancer Cell Line.
    Savukaitytė A; Gudoitytė G; Bartnykaitė A; Ugenskienė R; Juozaitytė E
    Cancer Manag Res; 2021; 13():1123-1133. PubMed ID: 33574709
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Kim SH; Singh KB; Hahm ER; Lokeshwar BL; Singh SV
    J Tradit Complement Med; 2020 May; 10(3):188-197. PubMed ID: 32670813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishing a relationship between prolactin and altered fatty acid β-oxidation via carnitine palmitoyl transferase 1 in breast cancer cells.
    Linher-Melville K; Zantinge S; Sanli T; Gerstein H; Tsakiridis T; Singh G
    BMC Cancer; 2011 Feb; 11():56. PubMed ID: 21294903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genes involved in fatty acid metabolism: molecular characterization and hypothalamic mRNA response to energy status and neuropeptide Y treatment in the orange-spotted grouper Epinephelus coioides.
    Tang Z; Sun C; Yan A; Wu S; Qin C; Zhang Y; Li W
    Mol Cell Endocrinol; 2013 Aug; 376(1-2):114-24. PubMed ID: 23806557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Withaferin A Inhibits Fatty Acid Synthesis in Rat Mammary Tumors.
    Singh KB; Hahm ER; Kim SH; Singh SV
    Cancer Prev Res (Phila); 2023 Jan; 16(1):5-16. PubMed ID: 36251722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer.
    Shao H; Mohamed EM; Xu GG; Waters M; Jing K; Ma Y; Zhang Y; Spiegel S; Idowu MO; Fang X
    Oncotarget; 2016 Jan; 7(4):3832-46. PubMed ID: 26716645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARα pathways.
    Li J; Huang Q; Long X; Zhang J; Huang X; Aa J; Yang H; Chen Z; Xing J
    J Hepatol; 2015 Dec; 63(6):1378-89. PubMed ID: 26282231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine-Tuning Lipid Metabolism by Targeting Mitochondria-Associated Acetyl-CoA-Carboxylase 2 in
    Valvo V; Iesato A; Kavanagh TR; Priolo C; Zsengeller Z; Pontecorvi A; Stillman IE; Burke SD; Liu X; Nucera C
    Thyroid; 2021 Sep; 31(9):1335-1358. PubMed ID: 33107403
    [No Abstract]   [Full Text] [Related]  

  • 10. Heterogeneity of fatty acid metabolism in breast cancer cells underlies differential sensitivity to palmitate-induced apoptosis.
    Balaban S; Lee LS; Varney B; Aishah A; Gao Q; Shearer RF; Saunders DN; Grewal T; Hoy AJ
    Mol Oncol; 2018 Sep; 12(9):1623-1638. PubMed ID: 30099850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-cholesten-3-one decreases breast cancer cell viability and alters membrane raft-localized EGFR expression by reducing lipogenesis and enhancing LXR-dependent cholesterol transporters.
    Elia J; Carbonnelle D; Logé C; Ory L; Huvelin JM; Tannoury M; Diab-Assaf M; Petit K; Nazih H
    Lipids Health Dis; 2019 Sep; 18(1):168. PubMed ID: 31477154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirtuin 3 improves fatty acid metabolism in response to high nonesterified fatty acids in calf hepatocytes by modulating gene expression.
    Liu L; Xing D; Du X; Peng T; McFadden JW; Wen L; Lei H; Dong W; Liu G; Wang Z; Su J; He J; Li X
    J Dairy Sci; 2020 Jul; 103(7):6557-6568. PubMed ID: 32331890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetyl-CoA Carboxylases and Diseases.
    Wang Y; Yu W; Li S; Guo D; He J; Wang Y
    Front Oncol; 2022; 12():836058. PubMed ID: 35359351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baicalein upregulates DDIT4 expression which mediates mTOR inhibition and growth inhibition in cancer cells.
    Wang Y; Han E; Xing Q; Yan J; Arrington A; Wang C; Tully D; Kowolik CM; Lu DM; Frankel PH; Zhai J; Wen W; Horne D; Yip MLR; Yim JH
    Cancer Lett; 2015 Mar; 358(2):170-179. PubMed ID: 25543165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of fatty acid synthase-dependent neoplastic lipogenesis as the mechanism of gamma-linolenic acid-induced toxicity to tumor cells: an extension to Nwankwo's hypothesis.
    Menendez JA; Colomer R; Lupu R
    Med Hypotheses; 2005; 64(2):337-41. PubMed ID: 15607568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetyl-CoA carboxylase from yeast is an essential enzyme and is regulated by factors that control phospholipid metabolism.
    Hasslacher M; Ivessa AS; Paltauf F; Kohlwein SD
    J Biol Chem; 1993 May; 268(15):10946-52. PubMed ID: 8098706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased mitochondrial fission drives the reprogramming of fatty acid metabolism in hepatocellular carcinoma cells through suppression of Sirtuin 1.
    Wu D; Yang Y; Hou Y; Zhao Z; Liang N; Yuan P; Yang T; Xing J; Li J
    Cancer Commun (Lond); 2022 Jan; 42(1):37-55. PubMed ID: 34981667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA damage-inducible transcript 4 (DDIT4) mediates methamphetamine-induced autophagy and apoptosis through mTOR signaling pathway in cardiomyocytes.
    Chen R; Wang B; Chen L; Cai D; Li B; Chen C; Huang E; Liu C; Lin Z; Xie WB; Wang H
    Toxicol Appl Pharmacol; 2016 Mar; 295():1-11. PubMed ID: 26825372
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Stüve P; Minarrieta L; Erdmann H; Arnold-Schrauf C; Swallow M; Guderian M; Krull F; Hölscher A; Ghorbani P; Behrends J; Abraham WR; Hölscher C; Sparwasser TD; Berod L
    Front Immunol; 2018; 9():495. PubMed ID: 29675017
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.